ERBB2 and breast carcinoma: We also obtained the similar results using other ErbB2‐overexpressing breast cancer cell lines (Fig. S1), MDA‐MB‐453 and SKBR3 in both of which miR‐205 expression was reduced compared with MCF10A (Fig. 1C,D).